Synopsis
0
EU WC
0
KDMF
0
VMF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONSUS Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - SOLUTION;INTRAVENOUS - 2500MG/50ML (...DOSAGE - SOLUTION;INTRAVENOUS - 2500MG/50ML (50MG/ML)
USFDA APPLICATION NUMBER - 210660
DOSAGE - SOLUTION;INTRAVENOUS - 500MG/10ML (5...DOSAGE - SOLUTION;INTRAVENOUS - 500MG/10ML (50MG/ML)
USFDA APPLICATION NUMBER - 210660
Digital Content
NEWS #PharmaBuzz
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
89
PharmaCompass offers a list of L-Cysteine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right L-Cysteine Hydrochloride manufacturer or L-Cysteine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred L-Cysteine Hydrochloride manufacturer or L-Cysteine Hydrochloride supplier.
A L-Cysteine Hydrochloride Monohydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of L-Cysteine Hydrochloride Monohydrate, including repackagers and relabelers. The FDA regulates L-Cysteine Hydrochloride Monohydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. L-Cysteine Hydrochloride Monohydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of L-Cysteine Hydrochloride Monohydrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A L-Cysteine Hydrochloride Monohydrate supplier is an individual or a company that provides L-Cysteine Hydrochloride Monohydrate active pharmaceutical ingredient (API) or L-Cysteine Hydrochloride Monohydrate finished formulations upon request. The L-Cysteine Hydrochloride Monohydrate suppliers may include L-Cysteine Hydrochloride Monohydrate API manufacturers, exporters, distributors and traders.
click here to find a list of L-Cysteine Hydrochloride Monohydrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A L-Cysteine Hydrochloride Monohydrate DMF (Drug Master File) is a document detailing the whole manufacturing process of L-Cysteine Hydrochloride Monohydrate active pharmaceutical ingredient (API) in detail. Different forms of L-Cysteine Hydrochloride Monohydrate DMFs exist exist since differing nations have different regulations, such as L-Cysteine Hydrochloride Monohydrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A L-Cysteine Hydrochloride Monohydrate DMF submitted to regulatory agencies in the US is known as a USDMF. L-Cysteine Hydrochloride Monohydrate USDMF includes data on L-Cysteine Hydrochloride Monohydrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The L-Cysteine Hydrochloride Monohydrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of L-Cysteine Hydrochloride Monohydrate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The L-Cysteine Hydrochloride Monohydrate Drug Master File in Japan (L-Cysteine Hydrochloride Monohydrate JDMF) empowers L-Cysteine Hydrochloride Monohydrate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the L-Cysteine Hydrochloride Monohydrate JDMF during the approval evaluation for pharmaceutical products. At the time of L-Cysteine Hydrochloride Monohydrate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of L-Cysteine Hydrochloride Monohydrate suppliers with JDMF on PharmaCompass.
A L-Cysteine Hydrochloride Monohydrate CEP of the European Pharmacopoeia monograph is often referred to as a L-Cysteine Hydrochloride Monohydrate Certificate of Suitability (COS). The purpose of a L-Cysteine Hydrochloride Monohydrate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of L-Cysteine Hydrochloride Monohydrate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of L-Cysteine Hydrochloride Monohydrate to their clients by showing that a L-Cysteine Hydrochloride Monohydrate CEP has been issued for it. The manufacturer submits a L-Cysteine Hydrochloride Monohydrate CEP (COS) as part of the market authorization procedure, and it takes on the role of a L-Cysteine Hydrochloride Monohydrate CEP holder for the record. Additionally, the data presented in the L-Cysteine Hydrochloride Monohydrate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the L-Cysteine Hydrochloride Monohydrate DMF.
A L-Cysteine Hydrochloride Monohydrate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. L-Cysteine Hydrochloride Monohydrate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of L-Cysteine Hydrochloride Monohydrate suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing L-Cysteine Hydrochloride Monohydrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for L-Cysteine Hydrochloride Monohydrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture L-Cysteine Hydrochloride Monohydrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain L-Cysteine Hydrochloride Monohydrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a L-Cysteine Hydrochloride Monohydrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of L-Cysteine Hydrochloride Monohydrate suppliers with NDC on PharmaCompass.
L-Cysteine Hydrochloride Monohydrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of L-Cysteine Hydrochloride Monohydrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right L-Cysteine Hydrochloride Monohydrate GMP manufacturer or L-Cysteine Hydrochloride Monohydrate GMP API supplier for your needs.
A L-Cysteine Hydrochloride Monohydrate CoA (Certificate of Analysis) is a formal document that attests to L-Cysteine Hydrochloride Monohydrate's compliance with L-Cysteine Hydrochloride Monohydrate specifications and serves as a tool for batch-level quality control.
L-Cysteine Hydrochloride Monohydrate CoA mostly includes findings from lab analyses of a specific batch. For each L-Cysteine Hydrochloride Monohydrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
L-Cysteine Hydrochloride Monohydrate may be tested according to a variety of international standards, such as European Pharmacopoeia (L-Cysteine Hydrochloride Monohydrate EP), L-Cysteine Hydrochloride Monohydrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (L-Cysteine Hydrochloride Monohydrate USP).
